| Document Date: 2011-12-01 14:42:37
Open Document File Size: 207,34 KBShare Result on Facebook
Company The Lancet Publishing Group / Heart Protection Study Collaborative Group / ACE / / Country United Kingdom / / / Facility Radcliffe Infirmary / / IndustryTerm telephone randomisation system / neurological imaging / anatomical site / Treatment for hypertension / / MedicalCondition intermittent claudication / vascular disease / strokes / dementia / peripheral arterial disease / myopathy / cirrhosis / cerebrovascular disease / non-melanoma skin cancer / non-fatal myocardial infarction / lower cardiovascular disease / prior disease / occlusive arterial disease / melanoma / nonfatal myocardial infarction / treated hypertension / angina / coronary heart disease / hepatitis / suspected myocardial infarction / inflammatory muscle disease / fatal strokes / coronary disease / liver disease / registered cancers / severe heart failure / cancers / peripheral vascular disease / hypertension / cancer / CHD / Myopathy No rhabdomyolysis Rhabdomyolysis ALT / disease / diagnosed coronary disease / severely disabling stroke / chronic / stroke / cognitive impairment / cardiovascular disease / diabetes / severe renal disease / psychiatric disorder / severe chronic airways / myocardial infarction / diabetes mellitus / heart failure / occlusive vascular disease / myocardial infarctions / dermatomyositis / polymyositis / sitespecific cancer / / MedicalTreatment carotid endarterectomy / angioplasty / surgery / coronary artery bypass surgery / statin therapy / contraception / bypass / Amputations / / Organization Steering Committee / / Position general practitioner / Major / / Product simvastatin / niacin / / ProvinceOrState Michigan / / URL www.hpsinfo.org / http /
SocialTag |
ARTICLES Articles MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in[removed]high-risk individuals: a randomised placebocontrolled trial